Cell proliferation induced by modified cationic dextran

Abstract The interaction between oppositely charged membranes and polycations causes cell aggregation, loss of membrane fluidity, and membrane degeneration and may cause an increase of its permeability. Unfortunately, the interaction is the reason why the use of polycations in medicine is severely limited. Therefore, in this paper, we share our observations related to the action of 40-kDa dextran modified using glycidyltrimethylammonium chloride, resulting in increased fibroblast cell proliferation. Using viability and proliferation tests [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, crystal violet, 3H-thymidine incorporation], we have observed that cationic dextran derivatives exert a positive impact on nonepithelial cell proliferation in vitro. This phenomenon has been noted for human and mouse fibroblasts and several other nonepithelial cell lines. However, the effect seems to be most pronounced for fibroblast cell lines. The presented studies allow to examine the impact of the polymer structure and the methods of its cationic modification on this newly observed phenomenon. The observation is unique because positively charged macromolecules usually exhibit high toxicity in all cell types in vitro.

[1]  A. Wellstein,et al.  Enhancement of Fibroblast Growth Factor (FGF) Activity by an FGF-binding Protein* , 2001, The Journal of Biological Chemistry.

[2]  Thomas Kissel,et al.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.

[3]  S. M. Lewis,et al.  Medical-Surgical Nursing , 1996, Definitions.

[4]  M. Nowakowska,et al.  Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis. , 2012, European journal of pharmacology.

[5]  H. Meiselman,et al.  Effects of dextran molecular weight on red blood cell aggregation. , 2008, Biophysical journal.

[6]  W. Rosenblum Effects of Dextran-40 on Blood Viscosity in Experimental Macroglobulinaemia , 1968, Nature.

[7]  N. Mason,et al.  A [polycation:heparin] complex releases growth factors with enhanced bioactivity. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[8]  J. Elferink Changes of plasma membrane permeability in neutrophils treated with polycations , 1991, Inflammation.

[9]  J. Bereta,et al.  Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin , 2015, PloS one.

[10]  Richard Hoogenboom,et al.  Cytotoxicity of polycations: Relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity. , 2017, International journal of pharmaceutics.